By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xeris Pharmaceuticals  

3925 West Braker Lane, Third Floor

Austin  Texas  78759  U.S.A.
Phone: 512-534-8340 Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Xeris Pharma Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program 6/16/2017 9:37:47 AM
Xeris Pharma’ Ready-To-Use Liquid Glucagon Clinical Data To Be Presented At American Diabetes Association 77th Scientific Sessions 6/5/2017 11:58:02 AM
Mérieux Développement Announces Equity Financing Into Xeris Pharma 5/19/2017 9:20:24 AM
Texas' Xeris Pharma Banks $30 Million From Old And New Investors 5/18/2017 6:59:54 AM
Xeris Pharmaceuticals To Present G-Pen Human Factors Study Results At 2016 ATTD Meeting 2/4/2016 12:15:16 PM
Xeris Pharmaceuticals Scores $41 Million Series C Financing 1/7/2016 8:53:00 AM
Xeris Pharmaceuticals Completes $17.9M Series B Round And Appoints Phillip Johnson As Chief Financial Officer 1/8/2015 7:32:19 AM
FDA And European Medicines Agency Grant Orphan Designation To Xeris Pharmaceuticals ' Soluble Glucagon For Prevention Of Hypoglycemia In Congenital Hyperinsulinism Patients 11/12/2014 10:31:58 AM
Xeris Pharmaceuticals Announces Dosing Of First Patient In Phase 2 Clinical Trial Of Its Investigational Soluble Glucagon For The Treatment Of Mild-To-Moderate Hypoglycemia 6/6/2014 8:54:40 AM
Xeris Pharmaceuticals Announces Dosing Of First Patient In Phase 2 Clinical Trial Of Its Investigational Soluble Glucagon Formulation For Pumps 4/25/2014 9:16:43 AM
12
//-->